Insider Trading Alert - GMCR, HOG And ESRX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 12, 2014, 136 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.01 to $1,795,652,303.10.

Highlighted Stocks Traded by Insiders:

Green Mountain Coffee Roasters (GMCR) - FREE Research Report

Wesley Norman H who is Director at Green Mountain Coffee Roasters bought 11,000 shares at $105.06 on March 12, 2014. Following this transaction, the Director owned 31,164 shares meaning that the stake was reduced by 54.55% with the 11,000-share transaction.

The shares most recently traded at $103.99, down $1.07, or 1.03% since the insider transaction. Historical insider transactions for Green Mountain Coffee Roasters go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 26,258
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 34,213
  • 24-Week # shares bought: 17,000
  • 24-Week # shares sold: 34,213

The average volume for Green Mountain Coffee Roasters has been 4.0 million shares per day over the past 30 days. Green Mountain Coffee Roasters has a market cap of $15.9 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 41.81% year-to-date as of the close of trading on Friday.

Green Mountain Coffee Roasters, Inc. is engaged in the specialty coffee and coffeemaker businesses in the United States and Canada. The company operates through two segments, Domestic and Canada. The stock currently has a dividend yield of 0.93%. The company has a P/E ratio of 31.8. Currently there are 8 analysts that rate Green Mountain Coffee Roasters a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GMCR - FREE

TheStreet Quant Ratings rates Green Mountain Coffee Roasters as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Green Mountain Coffee Roasters Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Harley-Davidson (HOG) - FREE Research Report

Brooks Martha who is Director at Harley-Davidson bought 95 shares at $48.00 on March 12, 2014. Following this transaction, the Director owned 370 shares meaning that the stake was reduced by 34.55% with the 95-share transaction.

The shares most recently traded at $67.41, up $19.41, or 28.79% since the insider transaction. Historical insider transactions for Harley-Davidson go as follows:

  • 4-Week # shares sold: 7,524
  • 12-Week # shares sold: 22,120
  • 24-Week # shares sold: 22,120

The average volume for Harley-Davidson has been 1.3 million shares per day over the past 30 days. Harley-Davidson has a market cap of $14.9 billion and is part of the consumer goods sector and automotive industry. Shares are down 2.11% year-to-date as of the close of trading on Friday.

Harley-Davidson, Inc. manufactures cruiser and touring motorcycles. The company operates in two segments, Motorcycles & Related Products and Financial Services. The stock currently has a dividend yield of 1.62%. The company has a P/E ratio of 20.7. Currently there are 11 analysts that rate Harley-Davidson a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HOG - FREE

TheStreet Quant Ratings rates Harley-Davidson as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Harley-Davidson Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Express Scripts (ESRX) - FREE Research Report

McNamee Patrick who is Exec. VP and COO at Express Scripts sold 68,425 shares at $78.28 on March 12, 2014. Following this transaction, the Exec. VP and COO owned 20,085 shares meaning that the stake was reduced by 77.31% with the 68,425-share transaction.

Miller Steven B who is Sr. VP & Chief Med. Officer at Express Scripts sold 12,664 shares at $77.96 on March 12, 2014. Following this transaction, the Sr. VP & Chief Med. Officer owned 21,417 shares meaning that the stake was reduced by 37.16% with the 12,664-share transaction.

The shares most recently traded at $78.64, up $0.68, or 0.86% since the insider transaction. Historical insider transactions for Express Scripts go as follows:

  • 4-Week # shares sold: 24,590
  • 12-Week # shares sold: 24,590
  • 24-Week # shares sold: 101,999

The average volume for Express Scripts has been 4.9 million shares per day over the past 30 days. Express Scripts has a market cap of $60.6 billion and is part of the health care sector and health services industry. Shares are up 11.18% year-to-date as of the close of trading on Friday.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. The company has a P/E ratio of 33.8. Currently there are 15 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ESRX - FREE

TheStreet Quant Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Nucor: Cramer's Top Takeaways

Nucor: Cramer's Top Takeaways

Trex Co.: Cramer's Top Takeaways

Trex Co.: Cramer's Top Takeaways

Duke Energy, Dominion, AT&T: 'Mad Money' Lightning Round

Duke Energy, Dominion, AT&T: 'Mad Money' Lightning Round

Jim Cramer: Why I Like the Keurig-Dr Pepper Merger

Jim Cramer: Why I Like the Keurig-Dr Pepper Merger

Canada Wildfires, Saudi Shakeup Lift Oil and Markets

Canada Wildfires, Saudi Shakeup Lift Oil and Markets